Crocs insider plans sale of 19,072 common shares

Crocs, Inc. (CROX) received a Form 144 notice indicating an intention to sell 19,072 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on or after August 10, 2026 on NASDAQ.

Rhea-AI Filing Summary

Crocs, Inc. (CROX) received a Form 144 notice indicating an intention to sell 19,072 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on or after August 10, 2026 on NASDAQ. The shares relate to previously granted Performance Stock Units and Restricted Stock issued as compensation. Related entities, including The Rees Family Living Trust and The Rees Family Foundation, sold additional common shares in the prior three months.

Key Figures

Shares to be sold: 19072 shares Aggregate market value of shares: 2649320.13 Shares outstanding: 47945075 shares +3 more

6 metrics

Shares to be sold 19072 shares Proposed sale of Crocs common stock under Form 144

Aggregate market value of shares 2649320.13 Reported aggregate market value for 19,072 shares

Shares outstanding 47945075 shares Crocs common shares outstanding referenced in Form 144

Trust sale 1 10928 shares for 1508248.20 Sale by The Rees Family Living Trust on 08/07/2026

Trust sale 2 32688 shares for 3860282.82 Sale by The Rees Family Living Trust U/A on 06/05/2026

Foundation sale 5000 shares for 538418.00 Sale by The Rees Family Foundation, Inc. on 05/21/2026

Key Terms

Form 144, Performance Stock Units, Restricted Stock Vesting Under a Registered Plan, Executive Financial Services

4 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Performance Stock Units financial

"Common | 08/17/2024 | Performance Stock Units | Issuer"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

Restricted Stock Vesting Under a Registered Plan financial

"03/03/2023 | Restricted Stock Vesting Under a Registered Plan"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Crocs (CROX) disclose in this Form 144 filing?

The filing indicates an intention to sell 19,072 Crocs common shares through Morgan Stanley Smith Barney on or after August 10, 2026 on NASDAQ, tied to prior equity compensation awards.

How many Crocs (CROX) shares are proposed to be sold under this Form 144?

The Form 144 covers a proposed sale of 19,072 shares of Crocs common stock, with an aggregate market value reported as 2649320.13 at the time of the notice.

What prior equity awards are linked to the Crocs (CROX) Form 144 shares?

The proposed sale relates to Performance Stock Units granted on 03/03/2023 and 08/17/2024, plus Restricted Stock vesting under a registered plan on 03/03/2023, totaling 19,072 shares.

Which broker is handling the planned Crocs (CROX) Form 144 share sale?

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, on NASDAQ.

What Crocs (CROX) insider-related sales occurred in the past three months?

Entities including The Rees Family Living Trust and The Rees Family Foundation, Inc. sold 10,928, 32,688, and 5,000 Crocs common shares, for proceeds of 1508248.20, 3860282.82, and 538418.00, respectively.

How many Crocs (CROX) shares were outstanding as referenced in this Form 144?

The Form 144 lists 47,945,075 Crocs common shares outstanding in connection with this planned sale, providing context for the size of the proposed 19,072-share transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 04:20 PM Accepted by SEC EDGAR 08/10/2026 - 04:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001609901
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CROCS, INC.
SEC File Number	000-51754
Address of Issuer	500 ELDORADO BOULEVARD BUILDING 5 BROOMFIELD COLORADO 80021
Phone	3038487000
Name of Person for Whose Account the Securities are To Be Sold	THE REES FAMILY LIVING TRUST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	19072	2649320.13	47945075	08/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/17/2024	Performance Stock Units	Issuer			1775	08/17/2024	Compensation
Common	03/03/2023	Performance Stock Units	Issuer			8854	03/03/2023	Compensation
Common	03/03/2023	Performance Stock Units	Issuer			5608	03/03/2023	Compensation
Common	03/03/2023	Restricted Stock Vesting Under a Registered Plan	Issuer			2835	03/03/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
THE REES FAMILY LIVING TRUST 500 Eldorado Blvd., Building 5, Broomfield CO 80021	Common	08/07/2026	10928	1508248.20
THE REES FAMILY LIVING TRUST U/A 500 Eldorado Blvd., Building 5, Broomfield CO 80021	Common	06/05/2026	32688	3860282.82
THE REES FAMILY FOUNDATION, INC. 500 Eldorado Blvd., Building 5, Broomfield CO 80021	Common	05/21/2026	5000	538418.00

144: Remarks and Signature

Remarks
Date of Notice	08/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew Rees, Trustee
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)